Nuvisan in the news
Contract research and development
Tamtam found 8 recent articles about Nuvisan.
- NUVISAN receives US$9.6m grant for a multi-target drug discovery program on novel non-hormonal contraceptive medicines
NUVISAN has secured a $9.6 million grant to develop novel non-hormonal contraceptive medicines.
- NUVISAN und ALS Limited unterzeichnen strategische Partnerschaft zur Erschließung neuer Märkte
NUVISAN partners with ALS Limited to expand into new markets and enhance its life sciences capabilities.
- Bayer moves 400 R&D jobs to CRO-run small molecules unit
Bayer is outsourcing 400 R&D jobs to Nuvisan's new Berlin center to focus on small molecule drug discovery as part of a major restructuring.
- Lohnhersteller Nuvisan übernimmt Auftragslabor Inamed
Nuvisan has acquired Inamed to enhance its clinical research capabilities and access to specialized patient populations.
- THE NUVISAN GROUP Continues Its Growth by Adding Parts of the GALDERMA R&D Capabilities from NESTLÉ SKIN HEALTH
NUVISAN Group is growing by acquiring Galderma's R&D capabilities from Nestlé Skin Health.
- THE NUVISAN GROUP Continues Its Growth by Adding Parts of the GALDERMA R&D Capabilities from NESTLÉ SKIN HEALTH
NUVISAN expanded by acquiring GALDERMA's R&D site in France, adding 80 employees and new drug development capabilities.
- NUVISAN-GROUP
NUVISAN expanded its early-stage drug development services by acquiring parts of GALDERMA's R&D site in France, adding 80 employees and new capabilities.
- Stabübergabe im Management der NUVISAN Gruppe: ADCURAM beruft die beiden Branchenexperten Dr. Christian Reh und Dr. Antal Hajos
NUVISAN's management transition aims to strengthen its market position and expand growth in clinical research.
Articles collected by Tamtam and kept when they are about the company, newest first. Each links to its source.
Selling to companies like Nuvisan?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies